Personalized medicine: Moving from simple theory to daily practice

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 7, 2015, Pages 959-960

  Lippi, Giuseppe ^a   Plebani, Mario ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC RESEARCH; CLINICAL PRACTICE; DNA POLYMORPHISM; EDITORIAL; EPIGENETICS; HEALTH CARE; HUMAN; INTERNET; LABORATORY PERSONNEL; METABOLOMICS; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEOMICS; REFERENCE VALUE; THEORY; TRANSCRIPTOMICS; CLINICAL CHEMISTRY; STANDARD;

BIOLOGICAL MARKER;

BIOMARKERS; CLINICAL CHEMISTRY TESTS; HUMANS; PRECISION MEDICINE; REFERENCE STANDARDS;

EID: 84930801242     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0291     Document Type: Editorial

References (17)

1. Plebani M, Lippi G. Personalized (laboratory) medicine: a bridge to the future. Clin Chem Lab Med 2013;51:703-6.
2. Baggio G, Corsini A, Floreani A, Giannini S, Zagonel V. Gender medicine: a task for the third millennium. Clin Chem Lab Med 2013;51:713-27.
3. Carlson B. What the devil is personalized medicine Biotechnol Healthc 2008;5:17-9.
4. Diamandis EP. Present and future of cancer biomarkers. Clin Chem Lab Med 2014;52:791-4.
5. Völzke H, Schmidt CO, Baumeister SE, Ittermann T, Fung G, Krafczyk-Korth J, et al. Personalized cardiovascular medicine: concepts and methodological considerations. Nat Rev Cardiol 2013;10:308-16.
6. Christaki E, Giamarellos-Bourboulis EJ. The beginning of personalized medicine in sepsis: small steps to a bright future. Clin Genet 2014;86:56-61.
7. Malentacchi F, Mancinia I, Brandslundb I, Vermeerschc P, Schwabd M, Marce J et al. Is laboratory medicine ready for the era of personalized medicine A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. Clin Chem Lab Med 2015;53:981-8.
8. Lippi G, Plebani M. Biomarker research and leading causes of death worldwide: a rather feeble relationship. Clin Chem Lab Med 2013;51:1691-3.
9. Lippi G, Jansen-Duerr P, Vinã J, Durrance-Bagale A, Abugessaisa I, Gomez-Cabrero D, et al., on behalf of the FRAILOMIC consortium. Laboratory biomarkers and frailty: presentation of the FRAILOMIC Initiative. Clin Chem Lab Med 2015; doi: 10.1515/cclm-2015-0147.
10. Plebani M. From symptoms to biomarkers: a change of paradigm. Clin Chem Lab Med 2014;52:1513-5.
11. Siest G, Henny J, Gräsbeck R, Wilding P, Petitclerc C, Queraltó JM, et al. The theory of reference values: an unfinished symphony. Clin Chem Lab Med 2013; 51:47-64.
12. Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, et al. Personalizing health care: feasibility and future implications. BMC Med 2013;11:179.
13. Plebani M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 2013;51:741-51.
14. Plebani M, Laposata M, Lundberg GD. The brain-to-brain loop concept for laboratory testing 40 years after its introduction. Am J Clin Pathol 2011;136:829-33.
15. Morse BL, Kim RB. Is personalized medicine a dream or a reality Crit Rev Clin Lab Sci 2015;52:1-11.
16. Annas GJ, Elias S. 23andMe and the FDA. N Engl J Med 2014;370:2248-9.
17. Lippi G, Mattiuzzi C. The biomarker paradigm: between diagnostic efficiency and clinical efficacy. Pol Arch Med Wewn. pii: AOP-15-026. [Epub ahead of print 2015 Feb 10].